These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19789327)

  • 1. Inhibiting the hypoxia response for cancer therapy: the new kid on the block.
    Koh MY; Spivak-Kroizman TR; Powis G
    Clin Cancer Res; 2009 Oct; 15(19):5945-6. PubMed ID: 19789327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel small molecule HIF-1alpha translation inhibitor.
    Narita T; Yin S; Gelin CF; Moreno CS; Yepes M; Nicolaou KC; Van Meir EG
    Clin Cancer Res; 2009 Oct; 15(19):6128-36. PubMed ID: 19789328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent agents targeting HIF-1α for cancer therapy.
    Hu Y; Liu J; Huang H
    J Cell Biochem; 2013 Mar; 114(3):498-509. PubMed ID: 22961911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1α and LOXL2.
    Chen X; Kou Y; Lu Y; Pu Y
    J Cell Biochem; 2020 Jan; 121(1):165-173. PubMed ID: 31162697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of P3971 an orally efficacious novel anticancer agent targeting HIF-1α and STAT3 pathways.
    Godse P; Kumar P; Yewalkar N; Deore V; Lohar M; Mundada R; Padgaonkar A; Manohar S; Joshi A; Bhatia D; Desai N; Damre A; Bhonde M; Joshi K; Sharma R; Kumar S
    Anticancer Agents Med Chem; 2013 Nov; 13(9):1460-6. PubMed ID: 24102269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural products as potent inhibitors of hypoxia-inducible factor-1α in cancer therapy.
    Zhong JC; Li XB; Lyu WY; Ye WC; Zhang DM
    Chin J Nat Med; 2020 Sep; 18(9):696-703. PubMed ID: 32928513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1 as a therapeutic target in cancer.
    Tang CM; Yu J
    J Gastroenterol Hepatol; 2013 Mar; 28(3):401-5. PubMed ID: 23173651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current insights and future perspectives of hypoxia-inducible factor-targeted therapy in cancer.
    Ajith TA
    J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):11-18. PubMed ID: 30260792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel therapeutic strategies that target HIF-1.
    Semenza GL
    Expert Opin Ther Targets; 2006 Apr; 10(2):267-80. PubMed ID: 16548775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets.
    Dimova EY; Michiels C; Kietzmann T
    Curr Pharm Des; 2009; 15(33):3867-77. PubMed ID: 19671044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of hypoxia-Inducible factor-1α participates in the epileptogenesis in animal models.
    Li J; Jiang G; Chen Y; Chen L; Li Z; Wang Z; Wang X
    Synapse; 2014 Sep; 68(9):402-9. PubMed ID: 24889205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecules targeting HIF-1α pathway for cancer therapy in recent years.
    Tang W; Zhao G
    Bioorg Med Chem; 2020 Jan; 28(2):115235. PubMed ID: 31843464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
    Li J; Xi W; Li X; Sun H; Li Y
    Bioorg Med Chem; 2019 Apr; 27(7):1145-1158. PubMed ID: 30819620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway.
    Huang L; Zhang Z; Zhang S; Ren J; Zhang R; Zeng H; Li Q; Wu G
    Int J Mol Med; 2011 Mar; 27(3):407-15. PubMed ID: 21249310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways.
    Wang JY; Wang Z; Li MY; Zhang Z; Mi C; Zuo HX; Xing Y; Wu YL; Lian LH; Xu GH; Piao LX; Ma J; Jin X
    Chem Biol Interact; 2018 Dec; 296():134-144. PubMed ID: 30266538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
    Fernandez EV; Reece KM; Ley AM; Troutman SM; Sissung TM; Price DK; Chau CH; Figg WD
    Mol Pharmacol; 2015 Jun; 87(6):1006-12. PubMed ID: 25829060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor-1alpha as a cancer drug target.
    Powis G; Kirkpatrick L
    Mol Cancer Ther; 2004 May; 3(5):647-54. PubMed ID: 15141023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical biology approach for the development of hypoxia inducible factor (HIF) inhibitor LW6 as a potential anticancer agent.
    Naik R; Han S; Lee K
    Arch Pharm Res; 2015 Sep; 38(9):1563-74. PubMed ID: 26310207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in antitumor research of HIF-1α inhibitor YC-1 and its derivatives.
    Ouyang C; Zhang J; Lei X; Xie Z; Liu X; Li Y; Huang S; Wang Z; Tang G
    Bioorg Chem; 2023 Apr; 133():106400. PubMed ID: 36739684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.